JP2012507278A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012507278A5 JP2012507278A5 JP2011533932A JP2011533932A JP2012507278A5 JP 2012507278 A5 JP2012507278 A5 JP 2012507278A5 JP 2011533932 A JP2011533932 A JP 2011533932A JP 2011533932 A JP2011533932 A JP 2011533932A JP 2012507278 A5 JP2012507278 A5 JP 2012507278A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- rnaset2
- seq
- truncated
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19313408P | 2008-10-30 | 2008-10-30 | |
| US61/193,134 | 2008-10-30 | ||
| PCT/IL2009/001012 WO2010049933A1 (en) | 2008-10-30 | 2009-10-29 | Efficient expression of truncated human rnaset2 in e. coli |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012507278A JP2012507278A (ja) | 2012-03-29 |
| JP2012507278A5 true JP2012507278A5 (cg-RX-API-DMAC7.html) | 2012-12-13 |
Family
ID=41694413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011533932A Pending JP2012507278A (ja) | 2008-10-30 | 2009-10-29 | 短縮型ヒトrnaset2の大腸菌における効率的発現 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110207667A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2346993A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012507278A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009309277A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2739705A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201100610A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010049933A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201102615B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013127752A1 (en) * | 2012-02-29 | 2013-09-06 | F. Hoffmann-La Roche Ag | Method for reduction of 1->3 reading frame shifts |
| EP3004339B1 (en) * | 2013-05-29 | 2021-07-07 | Cellectis | New compact scaffold of cas9 in the type ii crispr system |
| WO2015114633A1 (en) | 2014-01-30 | 2015-08-06 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. | Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same |
| CN109462996A (zh) | 2016-03-17 | 2019-03-12 | 西达-赛奈医疗中心 | 通过rnaset2诊断炎性肠病的方法 |
| WO2020112890A1 (en) | 2018-11-29 | 2020-06-04 | Cedars-Sinai Medical Center | Rnaset2 compositions and methods of treatment therewith |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001021830A1 (en) * | 1999-09-24 | 2001-03-29 | Ambion, Inc. | Nuclease inhibitor cocktail |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| WO2006035439A2 (en) * | 2004-09-29 | 2006-04-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Recombinant human t2 rnase and uses thereof |
| US7608413B1 (en) * | 2005-03-25 | 2009-10-27 | Celera Corporation | Kidney disease targets and uses thereof |
-
2009
- 2009-10-29 AU AU2009309277A patent/AU2009309277A1/en not_active Abandoned
- 2009-10-29 CA CA2739705A patent/CA2739705A1/en not_active Abandoned
- 2009-10-29 EA EA201100610A patent/EA201100610A1/ru unknown
- 2009-10-29 US US13/126,494 patent/US20110207667A1/en not_active Abandoned
- 2009-10-29 JP JP2011533932A patent/JP2012507278A/ja active Pending
- 2009-10-29 EP EP09760011A patent/EP2346993A1/en not_active Withdrawn
- 2009-10-29 WO PCT/IL2009/001012 patent/WO2010049933A1/en not_active Ceased
-
2011
- 2011-04-08 ZA ZA2011/02615A patent/ZA201102615B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013500050A1 (en) | Anticancer fusion protein | |
| HRP20201973T1 (hr) | Ligandi modificirani kružnom permutacijom kao agonisti i antagonisti | |
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| MX2019015502A (es) | L-asparaginasa modificada. | |
| NZ603348A (en) | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| IL199263A (en) | Glucagon peptide with enhanced solubility, pharmaceutical composition containing it and its uses for drug preparation | |
| JP2011528895A5 (cg-RX-API-DMAC7.html) | ||
| WO2013096868A3 (en) | Saposin-a derived peptides and uses thereof | |
| JP2015510393A5 (cg-RX-API-DMAC7.html) | ||
| JP2014529399A5 (cg-RX-API-DMAC7.html) | ||
| HRP20161458T1 (hr) | Polipeptidi, polinukleotidi i pripravci namijenjeni upotrebi u liječenju latentne tuberkuloze | |
| HRP20201081T1 (hr) | Inhibitorni peptidi porijeklom od trem-sličnog transkripta 1 (tlt-1) i njihove uporabe | |
| IN2014DN09963A (cg-RX-API-DMAC7.html) | ||
| JP2015533791A5 (cg-RX-API-DMAC7.html) | ||
| JP2012529293A5 (cg-RX-API-DMAC7.html) | ||
| JP2012102105A5 (cg-RX-API-DMAC7.html) | ||
| IL269187B1 (en) | Dominant active yap, a hippo effector, induces chromatin accessiblity and cardiomyocyte renewal | |
| JP2011521661A5 (cg-RX-API-DMAC7.html) | ||
| JP2015511599A5 (cg-RX-API-DMAC7.html) | ||
| RU2013111675A (ru) | Рекомбинантный fc-гибридный белок пятого домена фибронектина типа iii dcc | |
| JP2008545393A5 (cg-RX-API-DMAC7.html) | ||
| MX2009007261A (es) | Vacuna de peptido foxp3. | |
| JP2017513849A5 (cg-RX-API-DMAC7.html) | ||
| CN102311500B (zh) | 一种抗病毒融合蛋白及其应用 | |
| EA201300059A1 (ru) | Полипептид, обладающий активностью сволленина, и его применение |